论文部分内容阅读
Objective To observe the compliance to Imatinib(IM)400 mg/d in 513 patients with chronic myeloid leukemia chronic phase(CML-CP)referred to Henan Province Tumor Hospital from March 2013 through March2015 and its influence on cytogenetic response at 12months.Methods Of 513 patients with CML-CP from
Objective To observe the compliance to Imatinib (IM) 400 mg / d in 513 patients with chronic myeloid leukemia chronic phase (CML-CP) referred to Henan Province Tumor Hospital from March 2013 through March 2015 and its influence on cytogenetic response at 12 months. Mthods Of 513 patients with CML-CP from